Literature DB >> 33439451

Targeting PTB as a One-Step Procedure for In Situ Astrocyte-to-Dopamine Neuron Reprogramming in Parkinson's Disease.

Yuanyuan Jiang1,2, Yongjie Wang1,2, Zhihui Huang3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33439451      PMCID： PMC7954921          DOI： 10.1007/s12264-021-00630-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  14 in total

1.  Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.

Authors:  Sherri L Thiele; Ruth Warre; Joanne E Nash
Journal:  J Vis Exp       Date:  2012-02-14       Impact factor: 1.355

Review 2.  Astrocyte development: A Guide for the Perplexed.

Authors:  Anna Victoria Molofsky; Benjamin Deneen
Journal:  Glia       Date:  2015-05-12       Impact factor: 7.452

3.  Dopamine in Parkinson's Disease: Precise Supplementation with Motor Planning.

Authors:  Leilei Chen; Junxia Xie
Journal:  Neurosci Bull       Date:  2018-06-18       Impact factor: 5.203

4.  Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.

Authors:  Haibo Zhou; Jinlin Su; Xinde Hu; Changyang Zhou; He Li; Zhaorong Chen; Qingquan Xiao; Bo Wang; Wenyan Wu; Yidi Sun; Yingsi Zhou; Cheng Tang; Fei Liu; Linhan Wang; Canbin Feng; Mingzhe Liu; Sanlan Li; Yifeng Zhang; Huatai Xu; Haishan Yao; Linyu Shi; Hui Yang
Journal:  Cell       Date:  2020-04-08       Impact factor: 41.582

Review 5.  Milestones of Parkinson's Disease Research: 200 Years of History and Beyond.

Authors:  Song Li; Weidong Le
Journal:  Neurosci Bull       Date:  2017-09-11       Impact factor: 5.203

Review 6.  Parkinson disease.

Authors:  Werner Poewe; Klaus Seppi; Caroline M Tanner; Glenda M Halliday; Patrik Brundin; Jens Volkmann; Anette-Eleonore Schrag; Anthony E Lang
Journal:  Nat Rev Dis Primers       Date:  2017-03-23       Impact factor: 52.329

7.  Characterization of cDNAs encoding the polypyrimidine tract-binding protein.

Authors:  A Gil; P A Sharp; S F Jamison; M A Garcia-Blanco
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

Review 8.  Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.

Authors:  C Frank Bennett; Adrian R Krainer; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2019-07-08       Impact factor: 12.449

Review 9.  New approaches for brain repair-from rescue to reprogramming.

Authors:  Roger A Barker; Magdalena Götz; Malin Parmar
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

10.  Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.

Authors:  Gioele La Manno; Daniel Gyllborg; Simone Codeluppi; Kaneyasu Nishimura; Carmen Salto; Amit Zeisel; Lars E Borm; Simon R W Stott; Enrique M Toledo; J Carlos Villaescusa; Peter Lönnerberg; Jesper Ryge; Roger A Barker; Ernest Arenas; Sten Linnarsson
Journal:  Cell       Date:  2016-10-06       Impact factor: 41.582
View more
  2 in total

Review 1.  Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases.

Authors:  Matilde Contardo; Roberta De Gioia; Delia Gagliardi; Giacomo Pietro Comi; Linda Ottoboni; Monica Nizzardo; Stefania Corti
Journal:  Biomedicines       Date:  2022-02-07

2.  Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Weizhao Chen; Qiongping Zheng; Qiaoying Huang; Shanshan Ma; Mingtao Li
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.